CAN_399 |
origin: |
A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation. |
author: |
De Genst, E., Chan, P.H., Pardon, E., Hsu, S.T., Kumita, J.R., Christodoulou, J., Menzer, L., Chirga |
patent: |
no |
patent_application_number: |
null |
CDR1_seq: |
null |
CDR1_length: |
|
CDR2_seq: |
null |
CDR2_length: |
|
CDR3_seq: |
null |
CDR3_lentgh: |
|
protein_seq: |
QVQLQESGGGSVQAGGSLRLSCEASGLSTTVMAWFRQAPGKEREGVAAIYTGDGFPYYADSVKGRFTISQDNAKNRMYLQ
MNSLEPEDTAMYYCAAKTGAFSYGSLWWMSRAYNHWGQGTQVTVSSHHHHHH
|
DNA_seq: |
null |
PubMed_ID: |
23791944 |
PDB_ID: |
4I0C |
PDB_deposition_date: |
2012-11-16 |
PDB_released_date: |
2013-10-09 |
resolution: |
1.95Ã… |
source_organism: |
Camelus dromedarius |
experiment_method: |
dromedary immunization,library construction,pan,express |
antigen: |
wild-type human lysozyme(WT-HuL) |
antigen_chain: |
null |
antigen_seq: |
null |
function: |
therapeutics to combat protein misfolding diseases |
validationORprediction: |
Experimentally Validated |
epitope: |
null |
bacteria_family: |
Escherichia coli |
publication: |
J Phys Chem B. 2013 Oct 24;117(42):13245-58. doi: 10.1021/jp403425z. Epub 2013 Sep 24. |
|